Mustajoki P, Heinonen J
Anesthesiology. 1980 Jul;53(1):15-20. doi: 10.1097/00000542-198007000-00004.
To evaluate the risk of inducing acute symptoms after general anesthesia in patients with "inducible " porphyrias, the authors analyzed retrospectively the effects of 78 exposure to anesthesia in 47 patients, 33 with acute intermittent porphyria and 14 with variegate porphyria. On 62 occasions, 29 involving the use of a barbiturate, anesthesia was induced in 37 patients who had no porphyric symptoms at the time. None of these patients had an acute attack postoperatively. Anesthesia was induced 16 times in 14 patients during acute episodes; 12 of these patients also received precipitating drugs other than anesthetics. Porphyric symptoms worsened in seven in the ten patients who received thiopental and in two of the four who did not. In the latent stages of acute intermittent and variegate porphyria in this patient population, the risk of incurring symptoms after exposure to thiopental and/or other anesthetics was small. During an acute episode thiopental may aggravate porphyric symptoms.
为评估“可诱导性”卟啉病患者全身麻醉后诱发急性症状的风险,作者回顾性分析了47例患者78次麻醉暴露的影响,其中33例为急性间歇性卟啉病患者,14例为杂合性卟啉病患者。62次麻醉中,29次使用了巴比妥类药物,对37例当时无卟啉病症状的患者进行了麻醉诱导。这些患者术后均未发生急性发作。14例患者在急性发作期进行了16次麻醉诱导;其中12例患者还接受了除麻醉剂以外的诱发药物。接受硫喷妥钠的10例患者中有7例卟啉病症状加重,未接受硫喷妥钠的4例患者中有2例症状加重。在该患者群体的急性间歇性和杂合性卟啉病潜伏期,暴露于硫喷妥钠和/或其他麻醉剂后出现症状的风险较小。在急性发作期,硫喷妥钠可能会加重卟啉病症状。